Novel congenital myopathy locus identified in Native American Indians at 12q13.13-14.1

Center for Human Genetics, Duke University Medical Center, Box 3445, 595 LaSalle Street, Durham, NC 27710, USA.
Neurology (Impact Factor: 8.29). 11/2008; 71(22):1764-9. DOI: 10.1212/01.wnl.0000325060.16532.40
Source: PubMed


Native American myopathy (NAM) is an autosomal recessive congenital myopathy first reported in the Lumbee Indian people. Features of NAM include congenital weakness, cleft palate, ptosis, short stature, and susceptibility to malignant hyperthermia provoked by anesthesia.
We identified five individuals with NAM from the Lumbee population, and hypothesized that these affected individuals have disease alleles shared identical-by-descent inherited from common ancestry. To identify a NAM disease locus, homozygosity mapping methods were employed on a genomewide 10K single-nucleotide polymorphism (SNP) screen. To confirm regions of homozygosity identified in the SNP screen, microsatellite repeat markers were genotyped within those homozygous segments.
The SNP data demonstrated five regions of shared homozygosity in individuals with NAM. The additional genotyping data narrowed the region to one common segment of homozygosity spanning D12S398 to rs3842936 mapping to 12q13.13-14.1. Notably, loss of heterozygosity estimates from the SNP data also detected this same 12q region in the affected individuals.
This study reports the first gene mapping of Native American myopathy (NAM) using single-nucleotide polymorphism-based homozygosity mapping in only a few affected individuals from simplex families and identified a novel NAM locus. Identifying the genetic basis of NAM may suggest new genetic etiologies for other more common conditions such as congenital myopathy and malignant hyperthermia.

1 Follower
54 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: It has been suggested that the cardiac arrhythmia known as torsades de pointes could be caused by competing foci of triggered activity. To examine this competitive triggering hypothesis, we used a model of ventricular action potential propagation to simulate two separate zones of heterogeneous myocardium under electrophysiologic conditions that have been correlated with the occurrence of torsades de pointes. We found that the two zones could trigger competitively, and that the corresponding electrogram morphology alternates as observed during episodes of torsades de pointes. These preliminary results are in accord with the competitive triggering hypothesis
    Engineering in Medicine and Biology Society, 1994. Engineering Advances: New Opportunities for Biomedical Engineers. Proceedings of the 16th Annual International Conference of the IEEE; 02/1994
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The 12q13 region has been suggested as a candidate locus for orofacial cleft by different investigators. In the present study we tested the region for linkage with non syndromic cleft lip with or without cleft palate in a collection of 39 Italian multigenerational families, using microsatellite markers. No evidence of linkage was detected between the marker map and NSCLP under different mode of inheritance nor with a nonparametric method. Formal level of linkage exclusion, were obtained for each point of the map. Genetic heterogeneity and the different impact of the candidate locus among populations could explain conflicting results obtained in different studies.
    International journal of immunopathology and pharmacology 04/2011; 24(2 s):21-24. · 1.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: King-Denborough syndrome (KDS), first described in 1973, is a rare condition characterised by the triad of dysmorphic features, myopathy, and malignant hyperthermia susceptibility (MHS). Autosomal dominant inheritance with variable expressivity has been reported in several cases. Mutations in the skeletal muscle ryanodine receptor (RYR1) gene have been implicated in a wide range of myopathies such as central core disease (CCD), the malignant hyperthermia (MH) susceptibility trait and one isolated patient with KDS. Here we report clinical, pathologic and genetic features of four unrelated patients with KDS. Patients had a relatively uniform clinical presentation but muscle biopsy findings were highly variable. Heterozygous missense mutations in RYR1 were uncovered in three out of four families, of which one mutation was novel and two have previously been reported in MH. Further RyR1 protein expression studies performed in two families showed marked reduction of the RyR1 protein, indicating the presence of allelic RYR1 mutations not detectable on routine sequencing and potentially explaining marked intrafamilial variability. Our findings support the hypothesis that RYR1 mutations are associated with King-Denborough syndrome but that further genetic heterogeneity is likely.
    Neuromuscular Disorders 06/2011; 21(6):420-7. DOI:10.1016/j.nmd.2011.03.006 · 2.64 Impact Factor
Show more